Text Size

Metabolic Factors of Outcomes From Gastric Bypass Surgery (Cassini)

This study has been terminated.
(Study was terminated for business reasons.)
Sponsor:
Information provided by (Responsible Party):
Ethicon Endo-Surgery
ClinicalTrials.gov Identifier:
NCT01347840
First received: May 3, 2011
Last updated: April 19, 2012
Last verified: April 2012
History of Changes
Results First Received: April 19, 2012  
Study Type: Observational
Study Design: Observational Model: Case-Only;   Time Perspective: Prospective
Condition: Obesity

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
All Subjects This is a one arm study where all the subjects will receive the same treatment and will not be blinded. No subjects will be assigned to different treatment groups.

Participant Flow:   Overall Study
    All Subjects  
STARTED     1 [1]
COMPLETED     0  
NOT COMPLETED     1  
Withdrawal by Subject                 1  
[1] 1 subject enrolled but withdrew consent



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
All Subjects This is a one arm study where all the subjects will receive the same treatment and will not be blinded. No subjects will be assigned to different treatment groups.

Baseline Measures
    All Subjects  
Number of Participants  
[units: participants]
 		  1  
Age  
[units: participants]
 		 
<=18 years     0  
Between 18 and 65 years     1  
>=65 years     0  
Age  
[units: years]
Mean ± Standard Deviation 		  51  ± 0  
Gender  
[units: participants]
 		 
Female     0  
Male     1  
Region of Enrollment  
[units: participants]
 		 
United States     1  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Percent Excess Weight Loss   [ Time Frame: 16 months ]
  Show Outcome Measure 1

2.  Primary:   Resting Energy Expenditure   [ Time Frame: 16 months ]
  Show Outcome Measure 2

3.  Primary:   Area Under the Curve of Ghrelin and GLP-1   [ Time Frame: 16 months ]
  Show Outcome Measure 3

4.  Secondary:   Area Under the Curve of Timed Gastrointestinal Hormones (Insulin, GIP, Pancreatic Polypeptide, Peptide YY (PYY), Amylin, Glucagon, Pro-Insulin, C-Peptide)   [ Time Frame: 16 months ]
  Show Outcome Measure 4

5.  Secondary:   Adiponectin and Lectin   [ Time Frame: 16 months ]
  Show Outcome Measure 5

6.  Secondary:   Subject Questionnaires   [ Time Frame: 16 months ]
  Show Outcome Measure 6

7.  Secondary:   Area Under the Curve of Glucose   [ Time Frame: 16 months ]
  Show Outcome Measure 7

8.  Secondary:   Hemoglobin A1c and Lipid Panel   [ Time Frame: 16 months ]
  Show Outcome Measure 8

9.  Secondary:   Body Mass Index   [ Time Frame: 16 Months ]
  Show Outcome Measure 9

10.  Secondary:   Percent Weight Loss   [ Time Frame: 16 Months ]
  Show Outcome Measure 10


  Serious Adverse Events
  Show Serious Adverse Events


  Other Adverse Events
  Show Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Trial termination due to business needs. One subject enrolled and withdrew consent. Zero subjects completed study. No subject data analyzed.  


Results Point of Contact:  
Name/Title: Amy Mahanes
Organization: Ethicon Endo-Surgery, Inc.
phone: 513-337-8366
e-mail: amahanes@its.jnj.com


No publications provided


Responsible Party: Ethicon Endo-Surgery
ClinicalTrials.gov Identifier: NCT01347840     History of Changes
Other Study ID Numbers: CI-10-0004
Study First Received: May 3, 2011
Results First Received: April 19, 2012
Last Updated: April 19, 2012
Health Authority: United States: Institutional Review Board